Promyelocytic Acute
Mostrando 1-12 de 142 artigos, teses e dissertações.
-
1. Chronic myeloid leukemia developing in treated acute promyelocytic leukemia
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
2. Follow-up and outcome of the twelve-year experience in adult patients with acute promyelocytic leukemia
ABSTRACT Acute promyelocytic leukemia is a subtype of acute myeloid leukemia, characterized by the presence of neoplastic promyelocytes, due to the reciprocal balanced translocation between chromosomes 15 and 17. Currently, with the use of agents that act directly on this molecular change, such as all-trans retinoic acid and arsenic trioxide, APL has shifted
Hematol., Transfus. Cell Ther.. Publicado em: 2021-03
-
3. Molecular and hematologic relapses in adult patients with acute promyelocytic leukemia: a cohort study
Abstract Objective: To evaluate factors predictive for relapse in a cohort of adult patients with acute promyelocytic leukemia monitored by molecular methods during consolidation and during at least one month of maintenance therapy. Methods: The charts and laboratory data of 65 adult patients with acute promyelocytic leukemia treated according to the Inter
Rev. Bras. Hematol. Hemoter.. Publicado em: 2017-03
-
4. Administration of all-trans retinoic acid through enteral tubes in acute promyelocytic leukemia: the handling of cytotoxic agents and clinical benefits
Rev. Bras. Hematol. Hemoter.. Publicado em: 2017-03
-
5. Survival and treatment response in adults with acute promyelocytic leukemia treated with a modified International Consortium on Acute Promyelocytic Leukemia protocol
ABSTRACT Acute promyelocytic leukemia has good prognosis in view of the high complete remission and survival rates achieved with therapies containing all-trans retinoic acid or arsenic trioxide. However, there is a significant risk of death during induction due to hemorrhage secondary to disseminated intravascular coagulation. This has contributed to a gap i
Rev. Bras. Hematol. Hemoter.. Publicado em: 2016-12
-
6. Virginicin, a New Naphthalene from Kosteletzkya virginica (Malvaceae)
A new naphthalene, 8-methoxy-2,7-dihydroxyl-4-(1'-hydroxyl-isopropyl)-6-methyl-1-naphthaldehyde, together with twelve known compounds were isolated from the tubers of Kosteletzkya virginica. Their structures were elucidated by spectroscopic methods, including 1D-, 2D-nuclear magnetic resonance (NMR) and high-resolution time of flight electrospray ionization
J. Braz. Chem. Soc.. Publicado em: 2015-04
-
7. Possible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemia
In adults with non-promyelocytic acute myeloid leukemia (AML), high-dose cytarabine consolidation therapy has been shown to influence survival in selected patients, although the appropriate doses and schemes have not been defined. We evaluated survival after calculating the actual dose of cytarabine that patients received for consolidation therapy and divide
Braz J Med Biol Res. Publicado em: 12/12/2014
-
8. The Guidelines Project: Brazilian guidelines for acute promyelocytic leukemia
Rev. Bras. Hematol. Hemoter.. Publicado em: 2014-01
-
9. Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associacao Medica Brasileira - 2013
Rev. Bras. Hematol. Hemoter.. Publicado em: 2014-01
-
10. First reported case of pneumonia caused by Cedecea lapagei in America
Cedecea represents a genus in the Enterobacteriaceae family that has been rarely associated with human infection. The clinical relevance of Cedecea lapagei has yet to be elucidated. This is the first reported case of pneumonia due to C. lapagei in a patient with acute promyelocytic leukemia.
Braz J Infect Dis. Publicado em: 2013-10
-
11. The results of the International Consortium on Acute Promyelocytic Leukemia: a 'proof of concept' of networking as a strategy to improve the outcome of treatment of hematological malignancies in developing countries
Rev. Bras. Hematol. Hemoter.. Publicado em: 2013
-
12. Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia
Acute promyelocytic leukemia is characterized by gene rearrangements that always involve the retinoic acid receptor alpha on chromosome 15. In the majority of patients t(15;17) is detected, which generates the promyelocytic leukemia gene/retinoic acid receptor alpha rearrangement. This rearrangement interacts with several proteins, including the native promy
Revista Brasileira de Hematologia e Hemoterapia. Publicado em: 2012